NasdaqGM - Nasdaq Real Time Price USD

Mural Oncology plc (MURA)

2.9800
+0.1800
+(6.43%)
At close: May 20 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
138,613
138,262
196,238
184,923
175,365
Operating Income
-138,613
-138,262
-196,238
-184,923
-175,365
Other Income Expense
7,879
9,748
951
--
--
Pretax Income
-130,734
-128,514
-195,287
-184,923
-175,365
Tax Provision
--
0
12,160
4,884
68
Net Income Common Stockholders
-130,734
-128,514
-207,447
-189,807
-175,433
Diluted NI Available to Com Stockholders
-130,734
-128,514
-207,447
-189,807
-175,433
Basic EPS
-7.67
-7.58
-12.43
-11.37
-10.51
Diluted EPS
-7.67
-7.58
-12.43
-11.37
-10.51
Basic Average Shares
17,048.3650
16,954.5770
16,689.7400
16,688.1280
16,688.1280
Diluted Average Shares
17,048.3650
16,954.5770
16,689.7400
16,688.1280
16,688.1280
Total Operating Income as Reported
-138,613
-138,262
-196,238
-184,923
-175,365
Total Expenses
138,613
138,262
196,238
184,923
175,365
Net Income from Continuing & Discontinued Operation
-130,734
-128,514
-207,447
-189,807
-175,433
Normalized Income
-130,734
-128,514
-207,447
-189,807
-175,433
EBIT
-138,613
-138,262
-196,238
-184,923
-175,365
EBITDA
-135,096
-134,750
-193,671
-183,383
-173,891
Reconciled Depreciation
3,517
3,512
2,567
1,540
1,474
Net Income from Continuing Operation Net Minority Interest
-130,734
-128,514
-207,447
-189,807
-175,433
Normalized EBITDA
-135,096
-134,750
-193,671
-183,383
-173,891
Tax Rate for Calcs
0
0
0.0001
0.0001
0.0001
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/24/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MIST Milestone Pharmaceuticals Inc.
1.3900
+7.75%
 
GRCE Grace Therapeutics, Inc.
2.9675
-1.08%
 
LPCN Lipocine Inc.
3.6400
+0.28%
 
CRVS Corvus Pharmaceuticals, Inc.
3.6800
+1.66%
 
CRVO CervoMed Inc.
8.78
-0.11%
 
ACRV Acrivon Therapeutics, Inc.
1.2500
+5.93%
 
PYPD PolyPid Ltd.
2.9000
+3.20%
 
ITOS iTeos Therapeutics, Inc.
8.35
-0.71%
 
IRD Opus Genetics, Inc.
0.9940
-1.58%
 
TIL Instil Bio, Inc.
16.44
-2.72%